Caelum Biosciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $500M

Caelum Biosciences General Information

Description

Operator of a clinical-stage biotechnology comapny intended to develop treatments for rare and life-threatening conditions. The company is engaged in development of antibodies that work to break up pre-existing amyloid in tissues and to help the body's immune system remove the deleterious material, enabling patients with a greater chance to be a safe, receive well-tolerated therapy that promotes amyloid resolution and improve organ responses.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Rutgers Ecocomplex
  • 1200 Florence Road
  • Bordentown, NJ 08505
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caelum Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 06-Oct-2021 $500M 000.00 00000 Completed Clinical Trials - Phase 3
1. Early Stage VC 30-Jan-2019 000.00 000.00 Completed Clinical Trials - Phase 3
To view Caelum Biosciences’s complete valuation and funding history, request access »

Caelum Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biotechnology comapny intended to develop treatments for rare and life-threatening conditio
Biotechnology
Bordentown, NJ
000.00
00000 0000-00-00
000000&0 000.00

000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000 000000000
Vienna, Austria
00.00
0000000000 00.00

000000

por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis n
0000000000000
Redwood City, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Caelum Biosciences Competitors (61)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apeptico Venture Capital-Backed Vienna, Austria 00.00 0000000000 00.00
Adverum Biotechnologies Formerly VC-backed Redwood City, CA 000 00000 000000000 00000
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
Cardior Formerly VC-backed Hannover, Germany 00 00000 000000&0 00000
Glycomine Venture Capital-Backed San Carlos, CA 00 000.00 0000000000 0 000.00
You’re viewing 5 of 61 competitors. Get the full list »

Caelum Biosciences Patents

Caelum Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022346750-A1 Method of treating multiple myeloma Pending 14-Sep-2021 000000000
CA-3231073-A1 Method of treating multiple myeloma Pending 14-Sep-2021 000000000
AU-2021339851-A8 Method of treating amyloidosis Pending 14-Sep-2020 000000000
AU-2021339851-A1 Method of treating amyloidosis Pending 14-Sep-2020 000000000
CA-3192069-A1 Method of treating amyloidosis Pending 14-Sep-2020 C07K16/18
To view Caelum Biosciences’s complete patent history, request access »

Caelum Biosciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Columbia Technology Ventures University Minority 000 0000 000000 0
To view Caelum Biosciences’s complete investors history, request access »

Caelum Biosciences FAQs

  • When was Caelum Biosciences founded?

    Caelum Biosciences was founded in 2015.

  • Who is the founder of Caelum Biosciences?

    Michael Spector is the founder of Caelum Biosciences.

  • Where is Caelum Biosciences headquartered?

    Caelum Biosciences is headquartered in Bordentown, NJ.

  • What industry is Caelum Biosciences in?

    Caelum Biosciences’s primary industry is Biotechnology.

  • Is Caelum Biosciences a private or public company?

    Caelum Biosciences is a Private company.

  • What is the current valuation of Caelum Biosciences?

    The current valuation of Caelum Biosciences is 00000.

  • What is Caelum Biosciences’s current revenue?

    The current revenue for Caelum Biosciences is 000000.

  • How much funding has Caelum Biosciences raised over time?

    Caelum Biosciences has raised $69.9M.

  • Who are Caelum Biosciences’s investors?

    Columbia Technology Ventures has invested in Caelum Biosciences.

  • Who are Caelum Biosciences’s competitors?

    Apeptico, Adverum Biotechnologies, NexImmune, Cardior, and Glycomine are some of the 61 competitors of Caelum Biosciences.

  • When was Caelum Biosciences acquired?

    Caelum Biosciences was acquired on 06-Oct-2021.

  • Who acquired Caelum Biosciences?

    Caelum Biosciences was acquired by Alexion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »